Atara Biotherapeutics, Inc. ATRA
6.80 USD +0.46 (+7.31%)
As ofNov 20, 2026, 2:33 PM EST
6.25 Day range 6.85
3.92 52-week range 19.15
- YTD
- -62.39%
- 1 year
- -48.54%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 120.77M | 128.94M | 8.57M | 63.57M | 20.34M | |
| 120.77M | 128.94M | 8.57M | 63.57M | 20.34M | |
| 21.21M | 21.01M | 8.89M | 0 | 0 | |
| 99.56M | 107.93M | -313.00K | 63.57M | 20.34M | |
| 63.70M | 191.37M | 275.69M | 344.09M | 360.80M | |
| 37.45M | 151.48M | 224.78M | 272.53M | 282.00M | |
| 26.25M | 39.89M | 50.91M | 71.55M | 78.80M | |
| 35.86M | -83.44M | -276.01M | -280.51M | -340.46M | |
| 3.79M | 4.62M | 5.29M | 373.00K | -367.00K | |
| 31.00K | -12.00K | 15.00K | 12.00K | 46.00K | |
| 32.69M | -85.40M | -276.13M | -228.30M | -340.14M | |
| 32.69M | -85.40M | -276.13M | -228.30M | -340.14M | |
| 32.69M | -85.40M | -276.13M | -228.30M | -340.14M | |
| 32.69M | -85.40M | -276.13M | -228.30M | -340.14M | |
| 2.61 | -11.41 | -65.19 | -56.00 | -91.00 | |
| 2.61 | -11.41 | -65.19 | -56.00 | -91.00 | |
| 2.57 | -11.41 | -65.19 | -56.00 | -91.00 | |
| 36.51M | -80.80M | -270.83M | -227.92M | -340.46M | |
| 36.51M | -80.80M | -270.83M | -227.92M | -340.46M | |
| 12.54M | 7.49M | 4.24M | 4.08M | 3.75M | |
| 12.72M | 7.49M | 4.24M | 4.08M | 3.75M |
